Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Recapitulation of developmental mechanisms to revascularize the ischemic heart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Karina N. Dubé, … , Paul R. Riley, Nicola Smart
Published November 16, 2017
Citation Information: JCI Insight. 2017;2(22):e96800. https://doi.org/10.1172/jci.insight.96800.
View: Text | PDF
Research Article Cardiology

Recapitulation of developmental mechanisms to revascularize the ischemic heart

  • Text
  • PDF
Abstract

Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newly regenerated tissue. Endogenous vascular repair processes are deployed following injury but are poorly understood. We sought to determine whether developmental mechanisms of coronary vessel formation are intrinsically reactivated in the adult mouse after MI. Using pulse-chase genetic lineage tracing, we establish that de novo vessel formation constitutes a substantial component of the neovascular response, with apparent cellular contributions from the endocardium and coronary sinus. The adult heart reverts to its former hypertrabeculated state and repeats the process of compaction, which may facilitate endocardium-derived neovascularization. The capacity for angiogenic sprouting of the coronary sinus vein, the adult derivative of the sinus venosus, may also reflect its embryonic origin. The quiescent epicardium is reactivated and, while direct cellular contribution to new vessels is minimal, it supports the directional expansion of the neovessel network toward the infarcted myocardium. Thymosin β4, a peptide with roles in vascular development, was required for endocardial compaction, epicardial vessel expansion, and smooth muscle cell recruitment. Insight into pathways that regulate endogenous vascular repair, drawing on comparisons with development, may reveal novel targets for therapeutically enhancing neovascularization.

Authors

Karina N. Dubé, Tonia M. Thomas, Sonali Munshaw, Mala Rohling, Paul R. Riley, Nicola Smart

×

Figure 11

Thymosin β4 is required for trabecular compaction and endocardial contribution of de novo vessels.

Options: View larger image (or click on image) Download as PowerPoint
Thymosin β4 is required for trabecular compaction and endocardial contri...
Compared with WT (A), accumulation of trabeculae (B) and abnormal lumen morphology (C) were evident, by immunofluorescence, in Tβ4KO hearts from day 7 and more apparent by day 14 (D–F), a stage when compaction is mostly complete in WT (D); yet large trabeculae and lumina persisted in Tβ4KO hearts (E and F), suggesting a failure to undergo compaction remodeling and coalescence of new vessels. These defects manifested as a significant reduction in the incidence of subendocardial vessels formed (representative sections and quantification, G) from n = 10 hearts per genotype; 1-way ANOVA with Bonferroni correction for multiple comparisons; *P ≤ 0.05, **P ≤ 0.01, ***P < 0.001. This was associated with a striking reduction in αSMA+ cells in close proximity to Emcn+ endocardial cells (H–K). Scale bars: 1 mm (A, B, D, and E); 100 μm (C, F, H, and J); 20 μm (I and K)

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts